NO20072895L - Topiske sammensetninger inneholdende myrica gale olje - Google Patents

Topiske sammensetninger inneholdende myrica gale olje

Info

Publication number
NO20072895L
NO20072895L NO20072895A NO20072895A NO20072895L NO 20072895 L NO20072895 L NO 20072895L NO 20072895 A NO20072895 A NO 20072895A NO 20072895 A NO20072895 A NO 20072895A NO 20072895 L NO20072895 L NO 20072895L
Authority
NO
Norway
Prior art keywords
myrica
oil
mad
compositions containing
topical compositions
Prior art date
Application number
NO20072895A
Other languages
English (en)
Norwegian (no)
Inventor
Christopher Francis Smith
Edward Galley
Eilidh Ruth Benest
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO20072895L publication Critical patent/NO20072895L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20072895A 2004-11-11 2007-06-06 Topiske sammensetninger inneholdende myrica gale olje NO20072895L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424891A GB0424891D0 (en) 2004-11-11 2004-11-11 Topical compositions
PCT/GB2005/000016 WO2006051246A1 (fr) 2004-11-11 2005-01-05 Préparations pour application locale comprenant de l’huile de myrica gale

Publications (1)

Publication Number Publication Date
NO20072895L true NO20072895L (no) 2007-07-10

Family

ID=33523538

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072895A NO20072895L (no) 2004-11-11 2007-06-06 Topiske sammensetninger inneholdende myrica gale olje

Country Status (6)

Country Link
US (1) US20080069898A1 (fr)
EP (2) EP1809309A1 (fr)
CA (2) CA2586873C (fr)
GB (1) GB0424891D0 (fr)
NO (1) NO20072895L (fr)
WO (1) WO2006051246A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20130459T1 (en) * 2004-01-22 2013-06-30 University Of Miami Topical co-enzyme q10 formulations and methods of use
US20110129552A1 (en) * 2009-12-01 2011-06-02 Laderma Pty Ltd Acne Treatment
US8128916B2 (en) * 2005-06-16 2012-03-06 L'oréal Aqueous fatty quaternary amine-containing carrier systems for water-insoluble materials
US20090197819A1 (en) * 2007-03-20 2009-08-06 Clarence Albert Johnson Compositions for improving and repairing skin
US8454945B2 (en) 2007-03-22 2013-06-04 Berg Pharma Llc Topical formulations having enhanced bioavailability
BRPI0810948A8 (pt) * 2007-06-01 2017-05-09 Galderma Res & Dev "composição hidratante, usos da composição e método para hidratar ou umidificar a pele"
FR2925299A1 (fr) * 2007-12-21 2009-06-26 Oreal Utilisation de composition a base de peroxyde pour ameliorer l'aspect de la peau
JP6058263B2 (ja) 2008-04-11 2017-01-11 バーグ リミテッド ライアビリティ カンパニー 癌細胞においてアポトーシスを誘導する方法および使用
CN102176916A (zh) * 2008-06-05 2011-09-07 理查德·E·戴维森 包括纳米银的痤疮治疗组合物及其应用
US20090312224A1 (en) * 2008-06-13 2009-12-17 Conopco, Inc., D/B/A Unilever Method of Reducing Viscosity of Concentrated Liquid Cleansers by Selection of Perfume Components
US7833289B1 (en) 2009-04-15 2010-11-16 Alterna Holdings Corporation Hair care component and method of manufacture for use in a hair coloring system
CN105816498A (zh) 2009-04-27 2016-08-03 玫琳凯有限公司 植物性抗痤疮制剂
CN102481269B (zh) 2009-05-11 2015-10-07 博格有限责任公司 包含辅酶q10的药物组合物及其制备方法
BR112012022916B1 (pt) 2010-03-12 2021-11-09 Berg Llc Formulações intravenosas de coenzima q10 (coq10), bem como método de preparação e uso da mesma
CA2792857A1 (fr) * 2010-03-17 2011-09-22 Arbonne International Llc Composition topique de soin de la peau
JP6092844B2 (ja) 2011-04-04 2017-03-08 バーグ エルエルシー 中枢神経系腫瘍の治療方法
US20140239525A1 (en) 2011-06-17 2014-08-28 Board Of Regents, University Of Texas System Inhalable pharmaceutical compositions
FR2978041B1 (fr) 2011-07-21 2014-01-10 Lvmh Rech Solution parfumante stabilisee vis-a-vis des rayons ultraviolets
FR2978037B1 (fr) 2011-07-21 2014-01-10 Lvmh Rech Additif anti-ultraviolet comprenant un filtre uva, un filtre uvb et une huile solvant desdits filtres, son utilisation dans des compositions colorees et/ou parfumees.
ITRM20110400A1 (it) * 2011-07-27 2013-01-28 Uni Politecnica Delle Marche Nuove composizioni per la protezione solare.
WO2013096485A1 (fr) 2011-12-19 2013-06-27 Mary Kay Inc. Combinaison d'extraits de plantes destinée à améliorer le teint de la peau
WO2013149323A1 (fr) * 2012-04-02 2013-10-10 Ntegrity Produits naturels pour soins de la peau
DE102012210379A1 (de) * 2012-06-20 2013-12-24 Beiersdorf Ag Kosmetische und dermatologische Zubereitung enthaltend eine oder mehrere Substanz(en), die das Gen / Protein für den Rezeptor Endo180 modulieren
US20140010896A1 (en) * 2012-07-09 2014-01-09 Cynthia M. Chapman Composition for removing a tick and providing relief
US9295723B2 (en) 2013-03-01 2016-03-29 Envy Medical, Inc. Acne solution
US9433587B2 (en) 2013-03-01 2016-09-06 Envy Medical, Inc. Acne solution
US12440530B2 (en) 2013-03-01 2025-10-14 Envy Medical, Inc. Skin solution with solubilized bakuchiol
BR112015025424A2 (pt) 2013-04-08 2017-07-18 Berg Llc tratamento de câncer usando terapias de combinação de coenzima q10
US9724285B1 (en) * 2013-07-17 2017-08-08 Skindinavia, Inc. Use of stabilized vitamin B-6 (pyridoxine cyclic phosphate) in conjunction with skin cosmetics
MX381399B (es) 2013-09-04 2025-03-12 Berg Llc Formulaciones de coenzima q10 y métodos de uso.
EP3116469B1 (fr) 2014-03-10 2018-10-03 Mary Kay, Inc. Compositions d'éclaircissement de la peau
WO2015164433A1 (fr) * 2014-04-21 2015-10-29 Envy Medical, Inc. Solution contre l'acné
CN105109275A (zh) * 2015-08-18 2015-12-02 潘啟国 一种矿山用地跑轮
EP3162409A1 (fr) 2015-10-28 2017-05-03 The Procter and Gamble Company Procédé pour fournir un aspect brillant aux cheveux et compositions à utiliser avec celui-ci
EP3162408A1 (fr) 2015-10-28 2017-05-03 The Procter and Gamble Company Composition pour le brillant des cheveux et procédé d'utilisation
WO2017087576A1 (fr) 2015-11-16 2017-05-26 Berg Llc Procédés de traitement de gliome résistant au témozolomide utilisant la coenzyme q10
TW201729796A (zh) * 2016-02-17 2017-09-01 Ａａｋ美國股份有限公司 多功能結構性縮水甘油的／非縮水甘油的基質
US9949915B2 (en) * 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
PT3684477T (pt) * 2018-01-09 2022-06-07 Tomcat International Ltd Composições úteis para o tratamento cosmético da pele oleosa
CN112423727A (zh) * 2018-05-18 2021-02-26 康蔻香料有限公司 去屑组合物
IT201900006493A1 (it) 2019-05-02 2020-11-02 Alberto Denis Tombolato Crema dermatologica per il trattamento e la prevenzione di affezioni cutanee in campo oncologico
CN110731991B (zh) * 2019-07-30 2025-09-26 浙江养生堂天然药物研究所有限公司 具有祛痘功效的皮肤外用组合物
CN113350225B (zh) * 2020-03-04 2023-05-26 弘光科技大学 防晒精油组合物
JP2024162159A (ja) * 2023-05-09 2024-11-21 ロート製薬株式会社 外用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85111A1 (fr) * 1983-12-01 1985-09-12 Oreal Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
GB2224934B (en) * 1988-11-22 1992-01-08 Angus Erskine Stuart A new insect repellent of herbal origin
RU2082392C1 (ru) * 1994-06-29 1997-06-27 Евгения Яковлевна Яковенко Средство для ухода за волосами
FR2735026B1 (fr) * 1995-06-07 1997-08-22 Fabre Pierre Dermo Cosmetique Composition capillaire comprenant un extrait de myrte, son procede de preparation et son utilisation notamment pour un traitement antipelliculaire.
JPH0987619A (ja) * 1995-09-28 1997-03-31 Sanei Gen F F I Inc 酸化防止剤の製造法
FR2741265B1 (fr) * 1995-11-17 1998-12-31 Fabre Pierre Dermo Cosmetique Association extrait de myrte et antifongiques
FR2773711B1 (fr) * 1998-01-16 2001-05-04 Andre Pierre Morice Composition comprenant du miel, au moins une huile essentielle et/ou au moins un derive d'une huile essentielle
FR2783425B1 (fr) * 1998-09-17 2002-06-07 Fabre Pierre Dermo Cosmetique Extrait de myrte titre en myrtucommulone b', son procede de preparation et son application en dermatologie et en cosmetologie
CA2389814C (fr) * 2000-09-11 2009-07-28 San-Ei Gen F.F.I., Inc. Rouge de cochenille purifie et processus de production de ce pigment
GB2362574B (en) * 2001-01-12 2002-04-24 Angus Erskine Stuart A formulation for the destruction of the eggs of chicken mites (Dermanyssus Gallinae)
CA2449943A1 (fr) * 2001-06-15 2002-12-27 Kyowa Hakko Kogyo Co., Ltd. Agents de prevention ou remedes destines a l'arthrite
GB0224992D0 (en) * 2002-10-16 2002-12-04 Somerville Marie Insect repellent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Also Published As

Publication number Publication date
EP2070509A3 (fr) 2009-08-05
WO2006051246A1 (fr) 2006-05-18
CA2801903A1 (fr) 2006-05-18
EP1809309A1 (fr) 2007-07-25
US20080069898A1 (en) 2008-03-20
GB0424891D0 (en) 2004-12-15
CA2586873A1 (fr) 2006-05-18
CA2586873C (fr) 2013-03-19
EP2070509A2 (fr) 2009-06-17

Similar Documents

Publication Publication Date Title
PH12020550216A1 (en) Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
MX2022014942A (es) Nuevos compuestos.
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
WO2018136264A9 (fr) Composés de pyridine utilisés en tant qu'inhibiteurs allostériques de shp2
HK1244616A2 (zh) 一组保湿组合及其在制备保湿化妆品的应用
EA200870019A1 (ru) Лактамовые соединения и способы их применения
BR122020010667B8 (pt) inibidores de quinase, seus usos, e composição farmacêutica
MX2009009623A (es) Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide.
WO2007137066A3 (fr) Inhibiteurs hétérocycliques de la déshydrogénase du stéroïde hydroxyle 11-b de type 1 et leurs procédés d'utilisation
DK2358717T3 (da) Aminotetrahydropyraner som dipeptidylpeptidase-iv-inhibitorer tilbehandling eller forebyggelse af diabetes
MA33838B1 (fr) Forme amorphe et cristalline de l'hémitartrate de genz 112638 au titre d'inhibiteur de la glucosylcéramide synthétase
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
EP2070509A3 (fr) L'utilisation de l'huile de Myrica gale
MX2010009401A (es) Forma cristalina de derivado de fenilamino pirimidina.
WO2012154122A3 (fr) Formulation topique pour le traitement de la peau hyperkératosique
NZ630830A (en) Benzamides
WO2012112796A3 (fr) Compositions de perfluoro(n-butylcyclohexane) et leurs utilisations
EA201370191A1 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ МОДУЛЯТОРЫ ФАКТОРА КОАГУЛЯЦИИ VIIa, И ИХ ПРИМЕНЕНИЕ
EA201591180A1 (ru) Составы ингибитора lfa-1
ATE524486T1 (de) Lys-thr-dipeptide und deren verwendung
BR112015006063A2 (pt) compostos heteroaromáticos, processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
PT1871374E (pt) Pirazinossulfonamidas substituídas
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
SG194410A1 (en) Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
EA201290485A1 (ru) Производные бензамида

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application